NCT05021315 is a Phase 3 clinical trial of 10% povidone iodine in Cesarean Section Complications, sponsored by Cairo University.

Who is sponsoring NCT05021315?

NCT05021315 is sponsored by Cairo University.

What drugs are being tested in NCT05021315?

Interventions in NCT05021315: 10% povidone iodine.

What condition does NCT05021315 study?

NCT05021315 studies Cesarean Section Complications, Vaginal Infection, Postoperative Infection.

Is NCT05021315 still recruiting?

NCT05021315 is currently status unknown. Last updated 18 July 2022.

Last reviewed 2022-07-18 · How we verify

NCT05021315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection

Status unknown Phase 3 Last updated 18 July 2022

What this trial tests

Phase 3 trial testing 10% povidone iodine in Cesarean Section Complications in 800 participants. Status unknown.

Timeline

15 September 2021

Primary endpoint
30 September 2022

15 October 2022

Quick facts

Lead sponsor	Cairo University
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	800
Start date	15 September 2021
Primary completion	30 September 2022
Estimated completion	15 October 2022
Sites	2 locations across Egypt

Drugs / interventions tested

10% povidone iodine — full drug profile →

Conditions studied

Cesarean Section Complications — all drugs for Cesarean Section Complications →
Vaginal Infection — all drugs for Vaginal Infection →
Postoperative Infection — all drugs for Postoperative Infection →

Sponsor

Cairo University

Who can join

Adults 18 to 38, female only, with Cesarean Section Complications or Vaginal Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of work to assess the effectiveness of preoperative vaginal cleansing with povidone iodine on reduction of post caesarean section wound infection Research questions: Does vaginal cleaning using povidone iodine before cesarean section has effect on reduction of postoperative wound infection??

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of 10% povidone iodine

Trials testing the same drug.

NCT05896462 — Effect of Skin Antisepsis After Skin Closure on Wound Infection After Abdominal Surgery for Sepsis: a Preliminary Report · NA · completed

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
NCT07049705 — Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05021315 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 18 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05021315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing